BITPRISMIA
Nasdaq-listed Sonnet BioTherapeutics is merging with Rorschach I LLC to form Hyperliquid Strategies, a new public crypto treasury company valued at $888 million, focusing on HYPE tokens and leveraging a Nasdaq listing for strategic advantages.